European Archives - Page 3 of 1157 - European Medical Journal

Designing Life-Saving Neonatal Incubators: Interview with James Roberts

Conventional incubators haven’t changed for a long time; it’s been the same basic idea since the 1980s. A lot of people can recognise them…

Rising Bedaquiline Resistance Threatens Tuberculosis Control Efforts

Delayed sputum conversion and poor outcomes are common in patients with bedaquiline-resistant TB, according to a new South African cohort study.

Endometriosis Linked to Increased Risk of Autoimmune Conditions

A large-scale study found that women with endometriosis are nearly twice as likely to be diagnosed with autoimmune diseases like lupus, rheumatoid arthritis, or Hashimoto’s within two years.

Psoriasis Severity Strongly Linked to Metabolic Syndrome

The bidirectional relationship between psoriasis and MetS was supported by evidence showing that metabolic disturbances can also exacerbate psoriasis symptoms.

Breaking Barriers in Lung Cancer: Precision in Staging and Surgery

In the third episode of our lung cancer miniseries, Jonathan Sackier is joined by Douglas E. Wood to explore the critical role of lung cancer staging, the evolution of screening guidelines, and more.

Erratum: Advancements in Hydrogel-Based Therapies as Non-surgical Alternatives for Urothelial Carcinoma: Ongoing Research and New Insights

Psychiatric Symptoms Largely Overlooked in Urology Trials

Insomnia appeared in 61%, cognitive impairment and irritability in 38%, and more severe psychiatric issues such as psychosis and delirium were rarely considered.

Lennard Lee

Onc Now: Episode 20: How Cancer Vaccines Are Changing Medicine

Lennard Lee, Associate Professor of Cancer Vaccines at the University of Oxford, shares how large-scale collaboration is shaping the future of cancer vaccines and oncology innovation.

Genomic Sequencing Identifies Novel Genetic Loci in Spontaneous Pneumothorax

A genome-wide association study reveals four novel loci linked to primary spontaneous pneumothorax, identifying CBX7-mediated matrix dysregulation as a key pathogenic mechanism.

CEM After DBT Detects Hidden Cancers Missed by Standard Screening

Learn how CEM after DBT detects more early cancers in high-risk women, though with higher false positive rates.